mass drug administration

Dual-Purpose Public Health: Ivermectin Mass Drug Administration Reduces Malaria Incidence and Scabies Prevalence

By MedXY 01/13/2026

Large-scale trials in Kenya and Mozambique demonstrate that ivermectin mass drug administration significantly reduces malaria incidence by 26% and lowers community scabies prevalence, providing both direct protection and indirect herd-like benefits to untreated populations.

Public Health Specialties

Evaluating Community-Wide Mass Drug Administration to Interrupt Soil-Transmitted Helminth Transmission: Insights from the DeWorm3 Trial

By MedXY 08/27/2025

The DeWorm3 trial assessed whether high-coverage community-wide mass drug administration with albendazole could interrupt soil-transmitted helminth transmission in Benin, India, and Malawi but found limited success, suggesting tailored approaches are needed.

Clinical Updates news Pediatrics Specialties

Does Treating Older Siblings Enhance the Impact of Azithromycin on Infant Survival? Insights from a Cluster-Randomized Trial in Niger

By MedXY 08/04/2025

Mass azithromycin administration to both infants and older children reduced infant mortality more than treating infants alone, with potential spillover benefits from treating older siblings.